Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers.
Scope of the Report:
This report focuses on the Cell-Free DNA (cf-DNA) Testing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Cell-Free DNA (cf-DNA) Testing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche
Sequenom
Trovagene
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Donor-derived
Circulating
Cell-free
Market Segment by Applications, can be divided into
Oncology
Gynecology
Transplantation
There are 15 Chapters to deeply display the global Cell-Free DNA (cf-DNA) Testing market.
Chapter 1, to describe Cell-Free DNA (cf-DNA) Testing Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cell-Free DNA (cf-DNA) Testing, with sales, revenue, and price of Cell-Free DNA (cf-DNA) Testing, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cell-Free DNA (cf-DNA) Testing, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cell-Free DNA (cf-DNA) Testing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cell-Free DNA (cf-DNA) Testing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cell-Free DNA (cf-DNA) Testing Introduction
1.2 Market Analysis by Type
1.2.1 Donor-derived
1.2.2 Circulating
1.2.3 Cell-free
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Gynecology
1.3.3 Transplantation
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Agilent Technology
2.1.1 Business Overview
2.1.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Agilent Technology Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Allenex
2.2.1 Business Overview
2.2.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allenex Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biocept
2.3.1 Business Overview
2.3.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocept Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biodesix
2.4.1 Business Overview
2.4.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biodesix Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 CareDx
2.5.1 Business Overview
2.5.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CareDx Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Guardant Health
2.6.1 Business Overview
2.6.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Guardant Health Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Illumania
2.7.1 Business Overview
2.7.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Illumania Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Invited
2.8.1 Business Overview
2.8.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Invited Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Natera
2.9.1 Business Overview
2.9.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Natera Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Quest Diagnostics
2.10.1 Business Overview
2.10.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Roche
2.11.1 Business Overview
2.11.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Roche Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sequenom
2.12.1 Business Overview
2.12.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Sequenom Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Trovagene
2.13.1 Business Overview
2.13.2 Cell-Free DNA (cf-DNA) Testing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Trovagene Cell-Free DNA (cf-DNA) Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cell-Free DNA (cf-DNA) Testing Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cell-Free DNA (cf-DNA) Testing Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cell-Free DNA (cf-DNA) Testing Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cell-Free DNA (cf-DNA) Testing Manufacturer Market Share in 2017
3.3.2 Top 6 Cell-Free DNA (cf-DNA) Testing Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cell-Free DNA (cf-DNA) Testing Market Analysis by Regions
4.1 Global Cell-Free DNA (cf-DNA) Testing Sales, Revenue and Market Share by Regions
4.1.1 Global Cell-Free DNA (cf-DNA) Testing Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cell-Free DNA (cf-DNA) Testing Revenue and Market Share by Regions (2013-2018)
4.2 North America Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
4.3 Europe Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
4.5 South America Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
5 North America Cell-Free DNA (cf-DNA) Testing by Countries
5.1 North America Cell-Free DNA (cf-DNA) Testing Sales, Revenue and Market Share by Countries
5.1.1 North America Cell-Free DNA (cf-DNA) Testing Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cell-Free DNA (cf-DNA) Testing Revenue and Market Share by Countries (2013-2018)
5.2 United States Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
5.3 Canada Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
5.4 Mexico Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
6 Europe Cell-Free DNA (cf-DNA) Testing by Countries
6.1 Europe Cell-Free DNA (cf-DNA) Testing Sales, Revenue and Market Share by Countries
6.1.1 Europe Cell-Free DNA (cf-DNA) Testing Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cell-Free DNA (cf-DNA) Testing Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
6.3 UK Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
6.4 France Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
6.5 Russia Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
6.6 Italy Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cell-Free DNA (cf-DNA) Testing by Countries
7.1 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue and Market Share by Countries (2013-2018)
7.2 China Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
7.3 Japan Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
7.4 Korea Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
7.5 India Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
8 South America Cell-Free DNA (cf-DNA) Testing by Countries
8.1 South America Cell-Free DNA (cf-DNA) Testing Sales, Revenue and Market Share by Countries
8.1.1 South America Cell-Free DNA (cf-DNA) Testing Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cell-Free DNA (cf-DNA) Testing Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
8.3 Argentina Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
8.4 Colombia Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cell-Free DNA (cf-DNA) Testing by Countries
9.1 Middle East and Africa Cell-Free DNA (cf-DNA) Testing Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cell-Free DNA (cf-DNA) Testing Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cell-Free DNA (cf-DNA) Testing Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
9.3 UAE Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
9.4 Egypt Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
9.5 Nigeria Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
9.6 South Africa Cell-Free DNA (cf-DNA) Testing Sales and Growth Rate (2013-2018)
10 Global Cell-Free DNA (cf-DNA) Testing Market Segment by Type
10.1 Global Cell-Free DNA (cf-DNA) Testing Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cell-Free DNA (cf-DNA) Testing Sales and Market Share by Type (2013-2018)
10.1.2 Global Cell-Free DNA (cf-DNA) Testing Revenue and Market Share by Type (2013-2018)
10.2 Donor-derived Sales Growth and Price
10.2.1 Global Donor-derived Sales Growth (2013-2018)
10.2.2 Global Donor-derived Price (2013-2018)
10.3 Circulating Sales Growth and Price
10.3.1 Global Circulating Sales Growth (2013-2018)
10.3.2 Global Circulating Price (2013-2018)
10.4 Cell-free Sales Growth and Price
10.4.1 Global Cell-free Sales Growth (2013-2018)
10.4.2 Global Cell-free Price (2013-2018)
11 Global Cell-Free DNA (cf-DNA) Testing Market Segment by Application
11.1 Global Cell-Free DNA (cf-DNA) Testing Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Gynecology Sales Growth (2013-2018)
11.4 Transplantation Sales Growth (2013-2018)
12 Cell-Free DNA (cf-DNA) Testing Market Forecast (2018-2023)
12.1 Global Cell-Free DNA (cf-DNA) Testing Sales, Revenue and Growth Rate (2018-2023)
12.2 Cell-Free DNA (cf-DNA) Testing Market Forecast by Regions (2018-2023)
12.2.1 North America Cell-Free DNA (cf-DNA) Testing Market Forecast (2018-2023)
12.2.2 Europe Cell-Free DNA (cf-DNA) Testing Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Market Forecast (2018-2023)
12.2.4 South America Cell-Free DNA (cf-DNA) Testing Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cell-Free DNA (cf-DNA) Testing Market Forecast (2018-2023)
12.3 Cell-Free DNA (cf-DNA) Testing Market Forecast by Type (2018-2023)
12.3.1 Global Cell-Free DNA (cf-DNA) Testing Sales Forecast by Type (2018-2023)
12.3.2 Global Cell-Free DNA (cf-DNA) Testing Market Share Forecast by Type (2018-2023)
12.4 Cell-Free DNA (cf-DNA) Testing Market Forecast by Application (2018-2023)
12.4.1 Global Cell-Free DNA (cf-DNA) Testing Sales Forecast by Application (2018-2023)
12.4.2 Global Cell-Free DNA (cf-DNA) Testing Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cell-Free DNA (cf-DNA) Testing Picture
Table Product Specifications of Cell-Free DNA (cf-DNA) Testing
Figure Global Sales Market Share of Cell-Free DNA (cf-DNA) Test